200,000+ products from a single source!

sales@angenechem.com

Home > Thiazole > 136-16-3

136-16-3

136-16-3 | Thiazolium,3-[(3,4-dihydro-2-methyl-4-oxo-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)-4-methyl-

CAS No: 136-16-3 Catalog No: AG00714W MDL No:MFCD00050656

Product Description

Catalog Number:
AG00714W
Chemical Name:
Thiazolium,3-[(3,4-dihydro-2-methyl-4-oxo-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)-4-methyl-
CAS Number:
136-16-3
Molecular Formula:
C12H16ClN3O2S
Molecular Weight:
301.7923
MDL Number:
MFCD00050656
IUPAC Name:
5-[[5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium-3-yl]methyl]-2-methyl-1H-pyrimidin-6-one
InChI:
InChI=1S/C12H15N3O2S/c1-8-11(3-4-16)18-7-15(8)6-10-5-13-9(2)14-12(10)17/h5,7,16H,3-4,6H2,1-2H3/p+1
InChI Key:
SRDGSXVLAVRBLU-UHFFFAOYSA-O
SMILES:
OCCc1sc[n+](c1C)Cc1cnc(nc1O)C.[Cl-]
EC Number:
209-483-4
UNII:
1MF36SYZ22

Properties

Complexity:
395  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
266.096g/mol
Formal Charge:
1  
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
266.339g/mol
Monoisotopic Mass:
266.096g/mol
Rotatable Bond Count:
4  
Topological Polar Surface Area:
93.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.1  

Literature

Title Journal
Chemical and genetic validation of thiamine utilization as an antimalarial drug target. Nature communications 20130101
Thiamine is a substrate of organic cation transporters in Caco-2 cells. European journal of pharmacology 20120505
New considerations on the neuromodulatory role of thiamine. Pharmacology 20120101
JC virus T-antigen regulates glucose metabolic pathways in brain tumor cells. PloS one 20120101
Thiamin (vitamin B1) biosynthesis and regulation: a rich source of antimicrobial drug targets? International journal of biological sciences 20110101
Profiling pancreatic cancer-secreted proteome using 15N amino acids and serum-free media. Pancreas 20100101
Is transketolase like 1 a target for the treatment of differentiated thyroid carcinoma? A study on thyroid cancer cell lines. Investigational new drugs 20090801
Detection of transketolase in bone marrow-derived insulin-producing cells: benfotiamine enhances insulin synthesis and glucose metabolism. Stem cells and development 20090101
Synthesis, in vitro and in vivo activity of thiamine antagonist transketolase inhibitors. Bioorganic & medicinal chemistry letters 20080315
Involvement of thiaminase II encoded by the THI20 gene in thiamin salvage of Saccharomyces cerevisiae. FEMS yeast research 20080301
Comparative characteristic of thiamine antagonists on apoptosis induction in different types of nerve cell lines. Ukrains'kyi biokhimichnyi zhurnal (1999 ) 20080101
Hepatocyte susceptibility to glyoxal is dependent on cell thiamin content. Chemico-biological interactions 20070130
Thiamine deficiency caused by thiamine antagonists triggers upregulation of apoptosis inducing factor gene expression and leads to caspase 3-mediated apoptosis in neuronally differentiated rat PC-12 cells. Acta biochimica Polonica 20070101
Pentose phosphate cycle oxidative and nonoxidative balance: A new vulnerable target for overcoming drug resistance in cancer. International journal of cancer 20061215
Zinc(II), cadmium(II) and mercury(II) complexes of the vitamin B1 antagonist oxythiamine. Journal of inorganic biochemistry 20060101
Modification of thiamine pyrophosphate dependent enzyme activity by oxythiamine in Saccharomyces cerevisiae cells. Canadian journal of microbiology 20051001
Breakdown of 2-hydroxylated straight chain fatty acids via peroxisomal 2-hydroxyphytanoyl-CoA lyase: a revised pathway for the alpha-oxidation of straight chain fatty acids. The Journal of biological chemistry 20050318
C2-alpha-lactylthiamin diphosphate is an intermediate on the pathway of thiamin diphosphate-dependent pyruvate decarboxylation. Evidence on enzymes and models. The Journal of biological chemistry 20041224
Three thiamine analogues differently alter thiamine transport and metabolism in nervous tissue: an in vivo kinetic study using rats. Metabolic brain disease 20031201
Attempts to inhibit ruminal methanogenesis by blocking pyruvate oxidative decarboxylation. Canadian journal of microbiology 20031001
Evidence for a carrier-mediated mechanism for thiamine transport to human jejunal basolateral membrane vesicles. Digestive diseases and sciences 20030101
Effect of oxythiamin on growth rate, survival ability and pyruvate decarboxylase activity in Saccharomyces cerevisiae. Journal of basic microbiology 20030101
Cellular and molecular aspects of thiamin uptake by human liver cells: studies with cultured HepG2 cells. Biochimica et biophysica acta 20021223
Phenytoin ameliorates the memory deficit induced in the young chick by ethanol toxicity in association with thiamine deficiency. Pharmacology, biochemistry, and behavior 20020101
The effect of thiamine supplementation on tumour proliferation. A metabolic control analysis study. European journal of biochemistry 20010801
The use of thiamine and thiamine antagonists to investigate the etiology of early mortality syndrome in lake trout (Salvelinus namaycush). Aquatic toxicology (Amsterdam, Netherlands) 20010501

Related Products

© 2019 Angene International Limited. All rights Reserved.